Thirty cases of circulating vaccine-derived poliovirus type 2 have been recorded so far in Nigeria in 2022.
The figure is contained in the report of the Global Polio Eradication Initiative obtained by our correspondent on Sunday.
The report showed that there is one cVDPV2 positive environmental sample reported in Zamfara State.
A Professor of Public Health and former National Chairman of the Association of Public Health Physicians of Nigeria, Tanimola Akande, who spoke with our correspondent, said, “Government should intensify and improve on routine immunisation. The government is already putting some responses to the outbreak of vaccine-derived poliovirus through supplemental immunisation with the use of appropriate polio vaccine.
“The quality of such campaigns needs to be improved. Every stakeholder needs to be involved so that all children under five are reached during those campaigns,” he said.
A medical laboratory scientist at the Department of Microbiology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Obinna Chukwudi, stated, “Nigeria should be bothered as it is a strain related to the virus in OPV which contains the weakened-like polio virus found in the vaccine. This vaccine-derived polio is gotten by people who have not been immunised against polio or people who are under-immunised; those who for one reason or the other didn’t complete their vaccination against polio.
“Initially, OPV was the best against polio until we realised that it tends to re-infect people, especially unimmunised. So, the oral polio vaccine was replaced by the inactivated polio vaccine.
However, the government must start sensitising people about the advantages of early immunisation against polio. We can adapt using IPV that has zero tendencies of causing the vaccine-derived poliovirus. We must equally try to make the vaccines available in abundance.”
Reacting, the Executive Director and Chief Executive Officer of the National Primary Health Care Development Agency, Dr Faisal Shuaib, said there has been a 64%decline in Circulating Variant Polio Virus type 2 in 2022, compared to the same period in 2021.
Shuaib noted that, “the number of Acute Flaccid Paralysis cases has declined by 80%. So there is significant reduction and not an increase. This decrease is due to the campaigns that have been conducted to boost population immunity against the virus. The leadership provided by governors, traditional and religious leaders, dedicated frontline workers has been an essential part of this progress.”
“No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported this week. The number of cases in 2022 remains 30. There were 415 cases reported in 2021. One cVDPV2 positive environmental sample was reported in Zamfara,” the report read.
